|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-UMIN000002734 |
|
Date of registration:
|
10/11/2009 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Safety and effectiveness of Holmium Laser enucleation of the prostate in patients on ongoing oral antiplatelet therapy
|
|
Scientific title:
|
Safety and effectiveness of Holmium Laser enucleation of the prostate in patients on ongoing oral antiplatelet therapy - Safety and effectiveness of Holmium Laser enucleation of the prostate in patients on ongoing oral antiplatelet therapy |
|
Date of first enrolment:
|
2009/11/01 |
|
Target sample size:
|
80 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003268 |
|
Study type:
|
Interventional |
|
Study design:
|
Parallel Non-randomized
|
|
Phase:
|
Not selected
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
|
|
Address:
|
Japan |
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Okayama University Hospital General office |
|
|
Name:
|
Toyohiko Watanabe |
|
Address:
|
2-5-1, Shikata, Okayama
Japan |
|
Telephone:
|
086-235-7287 |
|
Email:
|
|
|
Affiliation:
|
Okayama University Hospital Urology |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: 1) Anesthesiologists (ASA) score of 4 or higher 2) Prostate cancer daignosed before HoLEP
Age minimum:
Not applicable
Age maximum:
Not applicable
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
Benign prostatic hypertrophy
|
|
Intervention(s)
|
Patient on ongoing antiplatelet therapy
Patient without oral antiplatelet trapy
|
|
Primary Outcome(s)
|
|
Persitent bleeding required cauterization of bleeders within 7 days after surgery
|
|
Secondary Outcome(s)
|
|
1)Blood transfusion 2)Postoperative decrease of Hb 3)IPSS, Qmax, PVR
|
|
Source(s) of Monetary Support
|
|
Okayama University Hospital
|
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
|
Results
|
|
Results available:
|
Yes |
|
Date Posted:
|
|
|
Date Completed:
|
01/03/2011 |
|
URL:
|
|
|
|